CASI Pharmaceuticals Inc. (CASIF) vs Ensysce Biosciences, Inc. (ENSC)
- CASI Pharmaceuticals Inc. CASIF 0.10 0.00%
- Ensysce Biosciences, Inc. ENSC 0.52 −13.33%
CASI Pharmaceuticals Inc. and Ensysce Biosciences, Inc. are both Biotechnology companies. CASI Pharmaceuticals Inc. and Ensysce Biosciences, Inc. are of similar size ($12.4M and $11.6M). CASI Pharmaceuticals Inc. grew revenue faster over the last twelve months: −27.4% against −39.3%. CASI Pharmaceuticals Inc. has the higher net margin (−232.0% vs −280.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, CASI Pharmaceuticals Inc. leads on 9 and Ensysce Biosciences, Inc. on 7.
Valuation
Profitability
| Metric | CASIF | ENSC | Biotechnology median |
|---|---|---|---|
| Gross margin | 48.65% | 100.00% | 65.16% |
| Operating margin | (206.87%) | (281.32%) | 0.00% |
| Net margin | (232.03%) | (280.49%) | 0.00% |
| Free cash flow margin | (340.20%) | (196.76%) | 0.00% |
| Return on equity | 0.00% | (1,295.01%) | (56.36%) |
| Return on assets | 0.00% | (295.92%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack